Relevium Technologies Inc. (TSX.V: “RLV”, OTC: “RLLVF” and
Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to
announce the successful delivery of Cleancare™ Hand Sanitizers to
retail customers in the in the US, including the orders announced
in a news release on April 15th of this year. The Company expects
to begin fulfillment for its B2C customers over the next 15 days as
it builds inventory levels.
BACKGROUNDOn April 2, 2020,
Relevium announced that it had sourced and would begin the
commercialization of a line of Bioganix Cleancare hand sanitizers,
in response to the COVID-19 pandemic. On April 15, 2020, the
Company announced that it had received initial orders totalling
$250,000 and that it would scale-up operations to meet market
demand.
SUCCESSFUL
DELIVERIES After an initial ramp up of production and
supply, the Company has successfully begun to deliver CleanCare™
Hand Sanitizers under market reasonable lead times, while working
to increase capacity, speed of supply and product format
offering.
The Company’s initial focus has been on
delivering CleanCare™ to US retailers and as disclosed in the
corporate regulatory news release dated June 2, 2020, the Company
has already begun to fulfill orders received in mid-April.
“The combination of the unusually high demand
created by COVID-19 and the scarcity of supply in the market
created long lead times for some of the critical components,
including alcohol and packaging supplies. These market conditions
led to the appearance of cheap, non-compliant imported products,
some of which have been recalled,” stated Aurelio Useche, CEO of
Relevium. Mr. Useche added, “We are extremely pleased to be able to
provide to the market and begun the successful delivery of a
premium and compliant product made in the US and Canada.”
CLEACARE™ LINE GUIDANCEThe
Company is currently focused on expanding its brick and mortar
retail network, primarily in the US, and expects the hand
sanitizing business to remain strong right through 2021. The
Company is also expanding the product line in terms of formats,
delivery methods and product specs in order to customize its
product line to the specific requirements of each retailer,
including co-branding, coloring, scents and others.
Although the product remains restricted in all
major online platforms, the Company has already applied to get
approval to sell on all its online marketplaces.
In terms of its recently announced air
purification systems, the Company is targeting to release the
product this fall in preparation for the expected potential second
wave of the COVID-19 virus.
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in policies
of the TSX Venture Exchange) accepts responsibility for the
adequacy or accuracy of this release.
About Relevium Technologies
Relevium is a publicly traded Company that
operates in the health and wellness industry, including legal
cannabis, with a primary focus on online distribution. The
principal business of the Company is the identification,
evaluation, acquisition and operation of brands and businesses in
the health and wellness markets and medical cannabis. The Company
pursues its business strategy through an acquisition and
partnership model in a holistic approach to encompass a wide range
of health and wellness consumer products. Relevium operates through
two wholly owned subsidiaries:
BGX E-Health LLC (BGX), based in Orlando,
Florida, markets dietary supplements, nutraceuticals, sports
nutrition, and cosmeceuticals primarily through its Bioganix® brand
portfolio in the US and Europe.
Relevium’s premium brands are sold at some of
the world’s largest retailers including Walmart.com and
Amazon.com.
Biocannabix Health Corporation (BCX), based in
Montreal, Quebec, is a biopharma nutraceutical Company focused on
delivering pediatric endo-medicinal nutraceuticals for cannabinoid
therapy.
Cautionary Note Regarding
Forward-Looking StatementsThis release includes
certain statements and information that may constitute
forward-looking information within the meaning of applicable
Canadian and United States securities laws. All statements in this
news release, other than statements of historical facts, including
statements regarding future estimates, plans, objectives,
assumptions, or expectations of future performance, are
forward-looking statements and contain forward-looking information.
Generally, forward- looking statements and information can be
identified by the use of forward-looking terminology such as
"intends" or "anticipates", or variations of such words and phrases
or statements that certain actions, events or results "may",
"could", "should", or "would" occur. Forward-looking
statements are based on certain material assumptions and analysis
made by the Company and the opinions and estimates of management as
of the date of this press release. These forward-looking statements
are subject to known and unknown risks, uncertainties and other
factors that may cause the actual results, level of activity,
performance or achievements of the Company to be materially
different from those expressed or implied by such forward-looking
statements or forward-looking information.
Although management of the Company has attempted
to identify important factors that could cause actual results to
differ materially from those contained in forward-looking
statements or forward-looking information, there may be other
factors that cause results not to be as anticipated, estimated or
intended. There can be no assurance that such statements will prove
to be accurate, as actual results and future events could differ
materially from those anticipated in such statements. Accordingly,
readers should not place undue reliance on forward- looking
statements and forward-looking information. Readers are cautioned
that reliance on such information may not be appropriate for other
purposes. The Company does not undertake to update any
forward-looking statement, forward-looking information or financial
outlook that are incorporated by reference herein, except in
accordance with applicable securities laws. We seek to rely on the
applicable safe harbor.
On Behalf of the Board of Directors
RELEVIUM TECHNOLOGIES
INC.
Aurelio UsechePresident and CEO
For more information about this press release:
Tel: +1.888.528.8687
RELEVIUM TECHNOLOGIES
INCEmail: investors@releviumcorp.com Website:
www.releviumtechnologies.com Like us on FacebookFollow us on
Twitter Follow us on LinkedIn
Relevium Technologies (TSXV:RLV)
Historical Stock Chart
From Jun 2024 to Jul 2024
Relevium Technologies (TSXV:RLV)
Historical Stock Chart
From Jul 2023 to Jul 2024